CIPLA
|
The Current P/B Ratio of CIPLA is 3.90.
Share Price | ₹1,500.5 | Jun 20,2025 |
Market Cap | ₹121,195.4 Cr | |
Book Value | ₹31,079.3 Cr | Mar2025 - Consolidated Results |
Price/Book | 3.90x | Calculated as MarketCap/Book Value |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PB (Price/Book ) ratio of CIPLA
P/B =
Market Capitalization
/ Book Value
or, using per-share numbers:
P/B = Stock Price /
Book Value Per Share
Current Market Cap [ ₹121,195.4 Cr] as on Jun 20,2025
(/) Book Value [ ₹31,079.3 Cr] based on Mar2025 - Consolidated Results
(=) P/B Ratio [ 3.90x ]
Thus, for CIPLA , the investors are currently willing to pay '3.90 times book value' to own 1 share of the company.
PB Multiples are one of the most widely used valuation multiple in industry.
Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.
In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of CIPLA !
The chart below summarizes the trend in P/B Ratio of CIPLA over the last five years.
Historical PB (Price/Book ) ratio chart of CIPLA
PB Ratio Performance Analysis for CIPLA
- CIPLA 's p/b ratio for fiscal years ending Mar2024 to Mar2020 averaged 3.47x.
- CIPLA 's operated at median p/b ratio of 3.6x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, CIPLA 's p/b ratio peaked in Mar2024 at 4.53x.
- CIPLA 's p/b ratio hit its five-year low in Mar2020 of 2.17x.
How does CIPLA 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Book Value | PB Ratio | Market Cap |
---|---|---|---|
CIPLA | 31,079.30 | 3.90 | 121,195.4 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 72,218.00 | 5.53 | 399,249.0 |
DIVIS LABORATORIES LTD | 14,969.00 | 11.69 | 174,940.0 |
TORRENT PHARMACEUTICALS LTD | 7,591.23 | 14.13 | 107,250.0 |
DR REDDYS LABORATORIES LTD | 33,549.60 | 3.30 | 110,618.0 |
MANKIND PHARMA LTD | 14,332.40 | 6.59 | 94,475.7 |
ZYDUS LIFESCIENCES LTD | 23,953.10 | 4.02 | 96,296.6 |
LUPIN LTD | 17,203.50 | 5.17 | 88,907.2 |
AUROBINDO PHARMA LTD | 32,653.30 | 1.95 | 63,667.5 |
ABBOTT INDIA LTD | 4,233.15 | 15.83 | 66,997.1 |
ALKEM LABORATORIES LTD | 11,984.90 | 4.77 | 57,113.8 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs CIPLA 's P/B Ratio
Top 10 Industry Peers | PB Ratio |
---|---|
Min industry PB | 1.95x |
Max industry PB | 15.83x |
Median industry PB | 5.17x |
Average industry PB | 6.99x |
You may also like the below Video Courses